{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for l root_references_url in Reference URL (approximate match)
Status:
Possibly Marketed Outside US
Source:
NDA202276
(2012)
Source URL:
First approved in 2002
Source:
ANDA091079
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA202834
(2012)
Source URL:
First approved in 2002
Source:
ANDA091079
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(1988)
Source URL:
First approved in 1988
Source:
21 CFR 348
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
USAN:ROMYELOCEL-L [USAN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(24)(i) menstrual/diuretic oil of erigeron
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M032
(2022)
Source URL:
First approved in 2022
Source:
M032
Source URL:
Class:
STRUCTURALLY DIVERSE
